In conclusion, our meta-analysis demonstrated that GnRH antagonist protocol substantially decreased the incidence of OHSS without influencing the pregnancy rate and live birth rate compared to GnRH agonist long protocol among patients with normal ovarian reserve. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.